Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM) is a chronic progressive disease, defined by insulin resistance and insufficient insulin secretion to maintain normoglycemia. Amyloidogenic aggregates are a hallmark of T2DM patients; they are cytotoxic for the insulin producing β-cells, and cause inflammasome-depende...
Guardado en:
Autores principales: | Anne-Cathrine S. Vogt, Elisa S. Roesti, Mona O. Mohsen, Ainars Leonchiks, Monique Vogel, Martin F. Bachmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e74c474167774d908f767972862a48e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
por: Jeong HR, et al.
Publicado: (2015) -
Single Molecule Measurements of the Accessibility of Molecular Surfaces
por: Arpan Dey, et al.
Publicado: (2021) -
Human Islet Amyloid Polypeptide Overexpression in INS-1E Cells Influences Amylin Oligomerization under ER Stress and Oxidative Stress
por: Yeong-Min Yoo, et al.
Publicado: (2021) -
Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
por: Taisei Tanaka, et al.
Publicado: (2021) -
Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
por: Brittany S. Bruggeman, et al.
Publicado: (2021)